Terran Biosciences Announces Acquisition of a Portfolio of Novel CNS Therapeutics from Concert Pharmaceuticals
By asianet
Terran Biosciences (“Terran”), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, has entered into an agreement with Concert Pharmaceuticals (“Concert”) to acquire a portfolio of Concert’s CNS therapeutics and accompanying intellectual property. Logo – https://mma.prnewswire.com/media/1758607/terran_biosciences_Logo.jpg These deuterated compounds represent next-generation therapeutics with applications across several different psychiatric … Continued